154 related articles for article (PubMed ID: 32964984)
1. LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2.
Xu DF; Tao XH; Yu Y; Teng Y; Huang YM; Ma JW; Fan YB
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8940-8946. PubMed ID: 32964984
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
Ou M; Li X; Zhao S; Cui S; Tu J
EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2.
Chen Y; Gu M; Liu C; Wan X; Shi Q; Chen Q; Wang Z
Gene; 2019 Feb; 686():37-42. PubMed ID: 30389560
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2.
Zhang B; Fan DB; Liu L; Qin Y; Feng DQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6533-6539. PubMed ID: 32633340
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
[TBL] [Abstract][Full Text] [Related]
7. The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8371-8376. PubMed ID: 31646567
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FOXC2 antisense transcript accelerates non-small-cell lung cancer tumorigenesis via silencing p15.
Sun Z; He C; Xiao M; Wei B; Zhu Y; Zhang G; Zhou H; Yuan J; Hu X; Yi Y
Am J Transl Res; 2019; 11(7):4552-4560. PubMed ID: 31396359
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
[TBL] [Abstract][Full Text] [Related]
10. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.
Chen L; Ma D; Li Y; Li X; Zhao L; Zhang J; Song Y
Int J Mol Med; 2018 Mar; 41(3):1275-1282. PubMed ID: 29286144
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53.
Zhao QS; Ying JB; Jing JJ; Wang SS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4382-4388. PubMed ID: 32373975
[TBL] [Abstract][Full Text] [Related]
12. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level.
Chen X; Wang K
Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
14. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
Wei LJ; Bai DM; Wang ZY; Liu BC
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
[TBL] [Abstract][Full Text] [Related]
16. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
17. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
Bai Y; Li S
J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
